U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H28N2O5S
Molecular Weight 468.5673
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EVATANEPAG

SMILES

CC(C)(C)c1ccc(cc1)CN(Cc2cccc(c2)OCC(=O)O)S(=O)(=O)c3cccnc3

InChI

InChIKey=WOHRHWDYFNWPNG-UHFFFAOYSA-N
InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29)

HIDE SMILES / InChI

Molecular Formula C25H28N2O5S
Molecular Weight 468.5673
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Evatanepag (CP-533,536) is a prostaglandin E2 EP2 receptor agonist. It stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing. Evatanepag was under development with Pfizer as a bone formation stimulant for therapeutic use in the healing of fractures.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
5 nM [EC50]
PubMed

PubMed

TitleDatePubMed
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.
2008 Jan 16
CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
2008 Oct
Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
2009 Apr 1
Patents
Substance Class Chemical
Created
by admin
on Sat Jun 26 00:44:23 UTC 2021
Edited
by admin
on Sat Jun 26 00:44:23 UTC 2021
Record UNII
L266R6E31E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EVATANEPAG
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
ACETIC ACID, 2-(3-((((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)(3-PYRIDINYLSULFONYL)AMINO)METHYL)PHENOXY)-
Common Name English
2-(3-((((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)(PYRIDIN-3-YLSULFONYL)AMINO)METHYL)PHENOXY)ACETIC ACID
Systematic Name English
CP-533536
Code English
EVATANEPAG [INN]
Common Name English
EVATANEPAG [WHO-DD]
Common Name English
EVATANEPAG [USAN]
Common Name English
CP-533,536
Code English
Classification Tree Code System Code
NCI_THESAURUS C78568
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
Code System Code Type Description
CAS
223488-57-1
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
DRUG BANK
DB12022
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
NCI_THESAURUS
C83707
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
INN
9151
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
PUBCHEM
9890801
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
FDA UNII
L266R6E31E
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
ChEMBL
CHEMBL563646
Created by admin on Sat Jun 26 00:44:23 UTC 2021 , Edited by admin on Sat Jun 26 00:44:23 UTC 2021
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY